Search results
Results from the WOW.Com Content Network
Isomyosamine, also known as MyMD-1 or MYMD-1, is a synthetic derivative of tobacco plant alkaloids being developed as a metabolic- and immunomodulator by MyMD Pharmaceuticals. To date, isomyosamine has been shown to suppress the production of IFN-γ , IL-2 , IL-10 , and TNF-α , and decrease the severity of experimental thyroiditis in a murine ...
Vion Pharmaceuticals has also filed several use patents concerning the antiviral and antifungal activity of 3AP. 3AP was initially developed by Vion Pharmaceuticals until company declared bankruptcy in December 2009. Nanotherapeutics, Inc. acquired the product from bankruptcy in 2010 and supported trials at NCI until 2018 when the product was ...
E. W. Kemble's "Death's Laboratory" on the cover of Collier's (June 3, 1905). A patent medicine, also known as a proprietary medicine or a nostrum (from the Latin nostrum remedium, or "our remedy") is a commercial product advertised to consumers as an over-the-counter medicine, generally for a variety of ailments, without regard to its actual effectiveness or the potential for harmful side ...
Image on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The global market for ...
For premium support please call: 800-290-4726 more ways to reach us
This patent-regime has the potential to limit access to life-saving vaccines and cures, especially for those in poor countries. [32] Pharmaceutical industry executives diminished the idea of sharing intellectual property, arguing that companies would have no incentive to innovate if their patents were considered worthless during a pandemic.
Pharmaceutical innovations are currently guided by a patent system, [1] the patent system protects the innovator of medicines for a period of time. The patent system does not currently stimulate innovation or pricing that provides access to medicine for those who need it the most, It provides for profitable innovation. [ 2 ]
Meanwhile, Fuisz continued to develop and secure patents through his family-owned private company, Fuisz LLC; in addition to health care innovations such as vaginal drug delivery, [47] thin-film-based smokeless tobacco and e-cigarettes, [2] and systems for monitoring addictive drug compliance, [48] Fuisz LLC also holds patents on wristwatches ...